New Delhi : Delhi-NCR’s emergence as India’s leading hub for AI-enabled robotic-assisted cardiac surgeries and India’s growing ambition to become a global leader in minimally invasive heart surgery were highlighted by leading cardiovascular and cardiothoracic surgeons during an international Cardiac Surgery conference in New Delhi. The developments were shared at the Society of Minimally Invasive Cardiovascular and Thoracic Surgeons of India (SMICTSI) 10th Annual Conference, being held alongside the 34th Annual Congress of the Association of Thoracic and Cardiovascular Surgeons of Asia (ATCSA), in collaboration with the 12th International Coronary Congress (ICC) and the workshop of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). The three-day international congress will take place from November 20–22, 2026, at Yashobhoomi , New Delhi, under the theme “Redefining Cardiothoracic Care: Global Trends and Transformative Technologies.” Around 1,200 delegates, including 300 international participants from more than 30 countries, are expected to attend. Hon’ble Lieutenant Governor of Delhi, Sardar Taranjit Singh Sandhu, will grace the inaugural ceremony as Chief Guest. The conference brings together leading international cardiac and thoracic surgeons, researchers and medical technology experts to discuss groundbreaking innovations, robotic-assisted interventions and the future of cardiovascular care.
According to details shared by experts during the press conference, Delhi-NCR currently leads India in AI-enabled robotic-assisted cardiac surgery, with 21 robotic cardiac surgery installations across the region. Approximately 1,800 robotic-assisted cardiac surgeries were performed in Delhi-NCR in 2025, placing it ahead of other major Indian cities, with Bengaluru emerging as the closest follower. The number of robotic-assisted cardiac procedures is expected to increase by approximately 40% in 2026, driven by the growing adoption of this technology across private and government hospitals. Currently, around 87% of robotic cardiac surgery installations are in private hospitals, while 13% are in government hospitals. Coronary Artery Bypass Grafting (CABG) accounts for the largest share of robotic-assisted cardiac procedures being performed in Delhi-NCR. Experts believe that the rapid expansion of robotic technology, increasing surgical expertise and growing patient acceptance could help India surpass the United States in the annual number of minimally invasive coronary artery bypass surgeries by 2031.
Dr. Yugal K. Mishra, Chairman, Organising Committee, SMICTSI 2026 and Chairman, Manipal Institute of Cardiac Sciences, New Delhi, said, “Delhi-NCR has emerged as a pioneer in robotic-assisted cardiac surgery in India because of its advanced medical infrastructure, early adoption of robotic technology and the presence of highly experienced cardiac surgical teams. We are witnessing a significant transformation in the way heart surgeries are performed, with robotics and artificial intelligence opening new possibilities for precision-driven and patient-centric treatment. Robotic systems provide surgeons with enhanced three-dimensional visualisation, greater instrument control and highly refined surgical movements, allowing complex procedures to be performed through smaller incisions. This minimally invasive approach can reduce surgical trauma, postoperative pain and complications, while enabling faster recovery and shorter hospital stays. AI-supported imaging, surgical planning and clinical decision-making are further strengthening this transformation. Delhi-NCR is playing a leading role in bringing these advancements into mainstream cardiac care.”
One of the most important advantages of robotic-assisted cardiac surgery is the enhanced precision it offers during complex procedures. The robotic platform provides magnified three-dimensional visualisation and allows surgeons to make controlled movements using specialised instruments designed to work in confined surgical spaces. Unlike conventional surgical instruments, robotic instruments offer enhanced articulation and flexibility, helping surgeons perform delicate manoeuvres with greater control.
Explaining the changing landscape of cardiac surgery, Dr. Y K Mishra further said, “The biggest advantage of robotic-assisted cardiac surgery is that it allows us to combine the surgeon’s expertise with the precision and capabilities of advanced technology. In procedures such as robotic-assisted CABG, surgeons can operate through smaller incisions without the need for a conventional full breastbone opening in appropriately selected cases. This can translate into less postoperative discomfort, reduced surgical trauma, quicker mobilisation and an earlier return to normal activities. We are also witnessing how AI and digital technologies are helping improve preoperative assessment, imaging and surgical planning. Our focus must be on making these advanced techniques more accessible and available to a larger number of patients.”
Delhi-NCR’s leadership in robotic cardiac surgery is supported by its strong ecosystem of tertiary-care hospitals, specialised cardiac sciences departments, experienced cardiothoracic surgeons and substantial investment in advanced medical technology. The region has developed multidisciplinary teams comprising cardiac surgeons, anaesthesiologists, perfusionists, intensivists and specialised nursing professionals, all of whom play an essential role in the success of complex robotic procedures.. The increasing presence of robotic systems in both private and government hospitals is expected to further expand access to advanced cardiac treatment. Experts believe that continued investment in infrastructure, surgeon training and research will be essential if India is to realise its ambition of becoming a global centre for minimally invasive cardiac surgery.
Artificial intelligence is also expected to play an increasingly important role in the next phase of cardiac surgery through advanced imaging analysis, preoperative risk assessment, surgical planning and data-supported clinical decision-making. Experts believe that the integration of robotics, AI and digital technologies will gradually make cardiac treatment more precise and personalised, while creating new opportunities for Indian surgeons to participate in global research, innovation and training programmes.
Dr. Rajneesh Malhotra, Secretary, Organising Committee, SMICTSI 2026 and Vice Chairman & Head, CTVS, Max Healthcare, Delhi, said, “Robotic-assisted and minimally invasive cardiac surgery are important developments that are changing the future of cardiovascular treatment. India has the clinical talent, growing technological infrastructure and patient volumes required to become a major global centre for these advanced procedures. Through SMICTSI 2026, we aim to bring together international expertise, share clinical experiences, discuss technological advancements and encourage greater training opportunities for young cardiac surgeons. This collaboration will help strengthen India’s capabilities and accelerate the adoption of safe, effective and affordable minimally invasive cardiac surgery.”
****

